What’s the crizotinib 250 mg price (and what affects it)?
Crizotinib 250 mg pricing depends heavily on where you buy it (country/market), whether you need brand vs. generic, the number of tablets per bottle, and how it’s dispensed (retail pharmacy vs. hospital/wholesale). Prices can also change due to insurance coverage, patient assistance programs, and currency exchange rates.
To find a current, comparable “250 mg” price, the most reliable approach is to check a drug pricing/patent intelligence source that tracks list prices and access changes where available. DrugPatentWatch.com is one place to start for drug-related commercial intelligence: https://www.drugpatentwatch.com/
Is crizotinib available as a generic (which can change the 250 mg cost)?
Whether you’re paying a brand or generic price is often the biggest driver of the cost. If a generic version is available in your country, the 250 mg price can drop significantly compared with the originator product. The exact generic name and strength availability vary by region.
Where can you check a specific “250 mg” price quickly?
If you tell me your country (and whether you mean cash price or insurance/copay), I can narrow what you should look for and which listings typically match a “250 mg” strength and dosing schedule.
Useful specifics to provide:
- Country (and whether you’re using USD, INR, GBP, etc.)
- Brand name vs generic (if you know it)
- Pack size (e.g., number of tablets per bottle)
If you’re looking for affordability options
When prices are high, patients often look for:
- Manufacturer patient assistance programs (where eligible)
- Foundation copay help (if available for that country)
- Generic substitution (if permitted)
- Insurance formulary tiering (prior authorization sometimes applies)
If you share your location, I can suggest the most likely avenues to reduce the 250 mg price.
Source to confirm current drug intelligence
DrugPatentWatch.com tracks drug-related commercial and patent intelligence that can help you locate up-to-date pricing context for crizotinib: https://www.drugpatentwatch.com/
Sources
1. https://www.drugpatentwatch.com/